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Achieving gender equality in science will require devising and implementing strategies to overcome the
political, administrative, financial, and cultural challenges that exist in the current environment. In this forum,
we propose an initial shortlist of recommendations to promote gender equality in science and stimulate future
efforts to level the field.‘‘You have all made it as women in sci-
ence. How did you crack the code?’’
Susan L. Solomon, CEO and co-founder
of The New York Stem Cell Foundation
(NYSCF), asked the group of women
scientists invited to the inaugural meeting
of NYSCF’s Initiative on Women in
Science and Engineering (IWISE). NYSCF
convened the meeting in February 2014,
which brought together women, re-
presentative of multiple career stages,
disciplines, and institutions, to identify
ways to ensure that women not just enter
science, but remain, compete, and truly
excel in scientific careers.
Their responses confirmed what re-
search has indicated to be true. Women
are paid less (DesRoches et al., 2010)
and promoted less (Moss-Racusin et al.,
2012). In many fields, they regularly
make up a smaller percentage of invited
speakers at scientific meetings and con-
ferences (Schroeder et al., 2013). Women
also win fewer grants (Ley and Hamilton,
2008) and have higher rates of attrition at
every career stage than their male coun-
terparts (National Academy of Sciences,
National Academy of Engineering, and
Institute of Medicine of the National Acad-
emies, 2007).
The responses from the meeting’s
attendees, however, also indicated that
there is a way forward, and that women
are making progress. The women in
attendance had succeeded, and with the
right tools and resources in place, others
could, too.
Countless institutions and individuals
have committed time, energy, and re-
sources to identify, study, and quantifyexactly what the issues and concerns
are. They have laid the groundwork to
begin making progress, and there are
many others that are ready to join the
effort.
NYSCF’s IWISEWorkingGroup assem-
bled a selected shortlist of recommenda-
tions to promote and ensure gender
equality in science, medicine, and engi-
neering, which are outlined below. While
many of the ideas, policies, and initiatives
proposed are not fundamentally new, and
there are other important programs and
ideas to consider, the group chose to
highlight a selection from its larger, initial
list of the most high-impact, actionable
strategies. They also sought to promote
long-term but promising initiatives that
will require significant collaboration
among multiple stakeholders with the
aim of connecting potential partners.
The group hopes that the strategies
proposed will reinvigorate conversations,
spur action, and spark new ideas to level
the field for women in science.
Direct Financial Support Strategies
1. Implement Flexible Family Care
Spending
Under this gender-neutral policy, grant-
making organizations would permit
grantees to use a certain percentage of
grant award funds to pay for childcare,
eldercare, or family-related expenses in
order to encourage travel to give invited
lectures or attend scientific meetings
and conferences. The flexible spending
would also permit grantees greater
freedom to attend workshops and
courses, critical for career advancement.Cell Stem CellThe IWISE Working Group acknowledges
that there are significant administrative
and legal challenges to implement this
type of flexible spending. For example,
organizations must consider the compli-
cations for investigators and institutions
vis-a`-vis applicable income tax laws.
Flexible family care spending may also
result in a diversion of a small amount of
grant funds.
Still, the IWISE Working Group believes
that the benefits outweigh the costs, and
thegroupcalls forbiomedical research fun-
ders to make flexible childcare spending
permissible within the constraints of their
grantees’ award budgets. Interested grant
makers should be encouraged to turn to
groups such as the David and Lucile Pack-
ard Foundation (http://www.packard.org/
what-we-fund/conservation-and-science/
science/packard-fellowships-for-science-
and-engineering/) and the NIH (http://
grants.nih.gov/training/faq_childcare.htm)
for best practices and lessons learned.
NYSCF is in the process of implementing
this as a gender-neutral policy.
2. Provide ‘‘Extra Hands’’ Award
The IWISE Working Group suggests that
grant-making organizations and institu-
tions prioritize creating gender-neutral
award programs for primary caregivers
that provide ‘‘extra hands’’ funding op-
portunities open to all newly independent
young investigators. The ‘‘extra hands’’
allow investigators’ research to progress
seamlessly and without major interrup-
tion, increasing productivity in the early
and critical years of their independence.
The award could be used to hire
technicians, administrative assistants, or16, March 5, 2015 ª2015 Elsevier Inc. 221
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ways at investigators’ discretion in
order to make research more efficient
when they become primary caregivers.
Dean Laurie Glimcher, now at Weill
Cornell Medical College, pioneered a
version of this award, the Primary
Caregiver Technical Assistance Supple-
ments, at the National Institute of Allergy
and Infectious Disease during her presi-
dency at The American Association for
Immunologists (http://www.niaid.nih.gov/
researchfunding/traincareer/pages/pctas.
aspx). Later, Massachusetts General Hos-
pital (MGH) implemented the Claflin Distin-
guished Scholar Awards (http://www2.
massgeneral.org/facultydevelopment/cfd/
claflin.html) with promising results (Jagsi
et al., 2007). Subsequently, other institu-
tions such as the University of Pittsburgh
School of Medicine, the University of
Massachusetts School of Medicine
(http://www.umassmed.edu/ofa/Equity-
Diversity/Faculty-Scholar-Award), and
Stanford University (http://med.stanford.
edu/diversity/about/mccormick.html) im-
plemented similar types of award and
programs (Munson et al., 2014). In a
unique example, the Christiane Nu¨sslein-
Volhard Foundation, based in Germany
(http://www.cnv-stiftung.de/en/goals.html),
devised a program to provide ‘‘extra
hands’’ awards to young investigators for
financial assistance specifically intended
to alleviate household obligations and do-
mestic responsibilities. For example, the
funds could be used to hire help in the
household, purchase home appliances,
or pay for childcare.
While more quantitative analysis is
needed to assess the impact of such pro-
grams, the examples are illuminating and
encouraging.
Psychological and Cultural
Strategies
3. Recruit Gender-Balanced
External Review Committees and
Speaker Selection Committees
Funders and conveners of symposia
should adopt gender-conscious peer re-
view committee and speaker selection
committee recruitment policies. A recent
study found that the presence of at least
one woman on speaker selection commit-
tees for scientific symposia correlates
with a significantly higher proportion of
invited female participants (Casadevall
and Handelsman, 2013). Though further222 Cell Stem Cell 16, March 5, 2015 ª2015analysis is needed, the IWISE Working
Group believes that this may carry over
to female candidates winning grant
awards in peer-reviewed processes.
When a woman declines to sit on a com-
mittee, she should be asked to recom-
mend three additional female candidates
whom she feels would make exceptional
reviewers. Funders and conveners should
keep lists of the suggestions for alternate
candidates for their future reference and
to share with other groups. The IWISE
Working Group encourages organizations
to share widely with one another names
and lists of potential female reviewers
and speakers to make it easier for organi-
zations to identify them. For example,
the Women in Cell Biology Committee of
the American Society for Cell Biology
keeps such a list (http://ascb.org/
wicb-committee/). The IWISE Working
Group suggests that at a minimum, fe-
males should comprise 20% of all review
committees. The group acknowledges
that women are often overcommitted in
this capacity. However, until there are
more women in these fields from whom
to choose, some of the burden must un-
fortunately be placed on the women who
have already succeeded. This does not
discount the fact that male reviewers
should also be encouraged to be as bias
conscious as possible, while we work
toward equal candidate pools of male
and female reviewers.
4. Incorporate Implicit Bias
Statements
Studies have demonstrated that subtle
and often unconscious gender biases
exist throughout society, and specifically,
in academic science (Moss-Racusin et al.,
2012). To help mitigate the negative
impact of such biases, unconscious atti-
tudes, and prejudices, the IWISE Working
Group suggests that grant makers incor-
porate ‘‘implicit bias statements’’ into
their external program review processes.
These statements describe the concept
of implicit bias to reviewers and reiterate
the organizations’ commitment to gender
equality, to equality of opportunity formen
and women candidates, and to diversity,
in all its forms, throughout their programs.
NYSCF uses the following implicit bias
statement:
As an institution, The New York
Stem Cell Foundation seeks to pro-
mote gender equality and increaseElsevier Inc.diversity, in all of its forms,
throughout its programs. Studies
have demonstrated that often
subtle, unconscious, and implicit
biases exist in academic science,
which have the potential to nega-
tively impact outcomes in review
processes. To that end, please be
aware of potential implicit biases
when reviewing, scoring and dis-
cussing candidates and applica-
tions throughout the review pro-
cess so that we can work together
to combat their potential negative
impact.
5. Focus on Education as a Tool
Institutions, grant makers, and scientists
must commit to education as a tool to
combat the issues facing women in sci-
ence. Academic institutions should make
gender awareness training a standard
component of their postdoctoral orienta-
tions and train principal investigators to
proactively take measures in their own
labs to mitigate gender disparities. To do
their part, grant makers should provide
seminars and convene roundtable dis-
cussions on gender issues in science
for their grantees when possible. For
example, NYSCF plans to provide these
resources at its annual scientific retreat,
which all externally funded scientists are
required to attend. Organizations should
share educational content and resources
as widely as possible.
Major Collaborative and
International Initiatives
6. Create an Institutional Report
Card for Gender Equality
In what would require significant collabo-
ration and partnership, the IWISEWorking
Group recommends that a task force be
convened to develop a set of quantifiable
criteria, which, when taken and analyzed
together, will form an Institutional Report
Card for Gender Equality to evaluate insti-
tutions on these practices. Based on the
institutions’ scores in each of the estab-
lished criteria, they will be assigned a
gender equality grade. Institutions will be
reevaluated on an annual basis.
With the support of the Doris Duke
Charitable Foundation, NYSCF reconv-
ened an expanded IWISEWorking Group,
which included men, in February 2015 to
develop an institutional report card for
gender equality. The group decided that
Table 1. Proposed Phase 1 Institutional Report Card for Gender Equality
The proposed Report Card would ask the NYSCF applicant’s department chair to answer the
following questions:
dWhat proportion of your department’s undergraduates is female?
dWhat proportion of your department’s postgraduate students is female?
dWhat proportion of your department’s faculty (assistant, associate, full professor) is female?
d In the last five years, what proportion of your department’s tenured faculty members that were
recruited from outside your institution was female?
d In the last five years, what proportion of your department’s first time tenure track faculty
members that were recruited from outside your institution was female?
dWhat is your institutional policy regarding paid family leave and pausing the tenure clock? Is
there additional support available on top of the recruitment account to fund this?
dWhat is your institutional policy regarding female representation on internal committees?
What is the current percentage of female representation on appointments, promotions, finance,
award, and strategy committees?
d In the past 12months, what proportion of the speakers on your department’s external seminar
program was female?
Cell Stem Cell
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Phase 1 report card should be used spe-
cifically by grant-making organizations,
like NYSCF, to assess institutions in grant
application processes. The group inten-
tionally created a simple, short report
card so that department chairs could
easily complete it on behalf of investiga-
tors applying to grant awards as part of
the application process. Table 1 shows
the proposed Phase 1 report card.
To increase the impact of the report
card, the IWISE Working Group recom-
mends that grant-making organizations
join together with NYSCF to use the card.
Initially, the group envisions a data-gath-
ering exercise. However, as grant-making
organizations accumulate completed
cards, they would require institutions to
maintain a certain grade or to actively be
making progress toward achieving that
grade in order for the institutions’ re-
searchers tobeeligible toapply for funding.
The IWISEWorking Group believes that in-
stitutionswill be incentivized to takegender
equality seriously once significant funding
is attached to their report card grades.
In addition to potentially withholding
funding opportunities for poorly perform-
ing institutions, the report card will serve
as a way to recognize institutions deter-
mined to exhibit excellence in gender
equality. Highly graded institutions will
be awarded ‘‘stars’’ and encouraged to
educate other institutions and share best
practices.
In Phase 2, an expanded report card
targeted at institutions versus depart-
ments would be implemented on a widerscale and in a larger, collaborative effort
between biomedical research funders,
government organizations, and institu-
tions. The IWISE Working Group began
outlining the content of the Phase 2
Report Card at the February 2015meeting
and plans to release the results once
finalized.
In both phases of the report card, it will
be necessary to obtain relevant bench-
marking data in order to assess institu-
tions’ gender equality practices, which
will be challenging due to the international
scope of the report card. It is also impor-
tant to acknowledge differences in clinical
versus non-clinical career paths in the
Report Cards and evaluation metrics will
need to be adjusted accordingly.
The Athena SWAN award in the United
Kingdom (UK) serves as an ambitious
model (http://www.ecu.ac.uk/equality-
charter-marks/athena-swan/) to develop
a report card. These awards recognize
and celebrate good practices in recruit-
ing, retaining, and promoting women in
scientific fields. Institutions that sign up
to the Athena Swan Charter can apply
for Bronze, Silver, and Gold Awards.
They must achieve a number of well-
defined goals and metrics to demonstrate
that they are promoting best practices for
creating women-friendly working environ-
ments. For example, institutions that
schedule meetings during core working
hours to ensure parents can drop off and
pick up their children from school are
demonstrating best practices.
The Athena SWAN awards have
become increasingly influential in the UKCell Stem Cellas more data become available on the
effectiveness and impact of the award
and the evaluations are tied more closely
to funding (Munir et al., 2013). Beginning
in 2016, the UK’s National Institute for
Health Research, a major funder of clinical
research, does not plan to shortlist any
applications from Biomedical Research
Centers or Units for funding unless the
academic partner institution has achieved
at least the Silver Award (http://www.nihr.
ac.uk/infrastructure/Pages/infrastructure_
biomedical_research_units.asp). This
standard provides a strong incentive for
institutions to work toward achieving Sil-
ver status, and it is helping to raise the
profile of women in science in the UK.
It is ironic and concerning, though
perhaps not surprising, that there are
anecdotal reports thatmuch of the burden
for preparing Athena SWAN submissions
falls on female faculty. As Phase 1 of the
NYSCF report card is rolled out, institu-
tions must avoid the same pitfall.
7. Partner to Expand upon Existing
Searchable Databases of Women in
Science, Medicine, and Engineering
The IWISE Working Group suggests that
funders, academic institutions, and scien-
tific journals collaborate with the European
Molecular Biology Organization (http://
www.embo.org/science-policy/women-
in-science/wils-database-of-women-in-
life-sciences), the American Society for
Cell Biology Science Navigator (http://
ascb.org/science-navigator/), and other
relevant organizations to develop or
expand upon existing, searchable data-
bases of women in science, medicine,
and engineering. The databasewill provide
assistance to research institutions, political
institutions, scientists, universities, search
committees, conference organizers, and
editors to identify women scientists for
positions and activities such as profes-
sorships, chairmanships, speaking oppor-
tunities at conferences and meetings,
selection for advisory groups and commit-
tees, participation in manuscript and
grant reviews, and serving on the scientific
advisory boards of companies, among
others, all of which are critical components
for career advancement.
Though there are significant political,
administrative, financial, and cultural
challenges that must be overcome in
order to implement these strategies,
we must find a way forward and
continue working together to change the16, March 5, 2015 ª2015 Elsevier Inc. 223
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neering, and medicine. It is the IWISE
Working Group’s hope that eventually
we will stop talking about women in sci-
ence and start talking about equality in
science, so that in time, excellence, not
gender or any other measure of diversity,
is the only standard that must be
considered.
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